279 related articles for article (PubMed ID: 35415228)
1. Graves Disease Following Subacute Thyroiditis in a Chinese Man.
Al-Bacha S; Lahiri SW
AACE Clin Case Rep; 2022; 8(2):73-77. PubMed ID: 35415228
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Subacute Thyroiditis in a Patient With Human Leukocyte Antigen-associated Predisposition to Graves Disease.
Yamakawa T; Sakakibara T; Terauchi Y
AACE Clin Case Rep; 2022; 8(3):113-115. PubMed ID: 35602878
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous occurrence of subacute thyroiditis and Graves' disease.
Hoang TD; Mai VQ; Clyde PW; Shakir MK
Thyroid; 2011 Dec; 21(12):1397-400. PubMed ID: 22136271
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
Liu T; Zhang X; Long L; Zhou L; Chen J; Li M; Gao Y; Zhou X; Han X; Ji L
BMC Endocr Disord; 2022 Aug; 22(1):218. PubMed ID: 36045442
[TBL] [Abstract][Full Text] [Related]
5. Differentiating Graves' disease from subacute thyroiditis using ratio of serum free triiodothyronine to free thyroxine.
Sriphrapradang C; Bhasipol A
Ann Med Surg (Lond); 2016 Sep; 10():69-72. PubMed ID: 27570620
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Functional Thyroid-Stimulating and Thyroid-Blocking Immunoglobulin Bioassays in an Atypical Presentation of Graves' Disease.
Sherfan J; Samad N; Hsieh A; Sullivan D; Fuller PJ
AACE Clin Case Rep; 2023; 9(3):67-70. PubMed ID: 37251977
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma.
Gubbi S; Al-Jundi M; Del Rivero J; Jha A; Knue M; Zou J; Turkbey B; Carrasquillo JA; Lin E; Pacak K; Klubo-Gwiezdzinska J; Lin FI
Front Endocrinol (Lausanne); 2020; 11():587065. PubMed ID: 33551992
[TBL] [Abstract][Full Text] [Related]
8. Elevated Graves' Disease-Specific Thyroid-Stimulating Immunoglobulin and Thyroid Stimulating Hormone Receptor Antibody in a Patient With Subacute Thyroiditis.
Alvin Mathew A; Papaly R; Maliakal A; Chandra L; Antony MA
Cureus; 2021 Nov; 13(11):e19448. PubMed ID: 34912598
[TBL] [Abstract][Full Text] [Related]
9. HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.
Yasuda S; Suzuki S; Yanagisawa S; Morita H; Haisa A; Satomura A; Nakajima R; Oikawa Y; Inoue I; Shimada A
BMC Endocr Disord; 2023 Mar; 23(1):54. PubMed ID: 36879263
[TBL] [Abstract][Full Text] [Related]
10. POSITIVE THYROTROPIN RECEPTOR ANTIBODIES IN PATIENTS WITH TRANSIENT THYROTOXICOSIS.
Angell TE; Van Benschoten O; Cohen DA; Haas AV; Alexander EK; Marqusee E
Endocr Pract; 2018 Jun; 24(6):512-516. PubMed ID: 29624097
[TBL] [Abstract][Full Text] [Related]
11. Free triiodothyronine to free thyroxine ratio in the differential diagnosis of thyrotoxicosis and hyperthyroidism: A retrospective study.
Tura Bahadır Ç; Yılmaz M; Kılıçkan E
Int J Clin Pract; 2021 May; 75(5):e14003. PubMed ID: 33403716
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of thyroid-stimulating immunoglobulin detection for diagnosing Graves' disease and predictors of responsiveness to methimazole.
Liu K; Fu Y; Li T; Liu S; Chen D; Zhao C; Shi Y; Cai Y; Yang T; Zheng X
Clin Biochem; 2021 Nov; 97():34-40. PubMed ID: 34331946
[TBL] [Abstract][Full Text] [Related]
13. Subacute thyroiditis associated with thyrotoxic periodic paralysis after COVID-19 vaccination: a case report.
Murashita M; Wada N; Baba S; Sugawara H; Miyoshi A; Obara S
Endocrinol Diabetes Metab Case Rep; 2022 May; 2022():. PubMed ID: 35578985
[TBL] [Abstract][Full Text] [Related]
14. Extremely high doses of radioiodine required for treatment of Graves' hyperthyroidism: a case report.
Neto AM; Tambascia MA; Brunetto S; Ramos CD; Zantut-Wittmann DE
Cases J; 2009 Aug; 2():8479. PubMed ID: 19918435
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the application of TSH receptor stimulating autoantibodies and the optimization of detection strategy in Graves' disease.
Tong M; Ding J; Huang B; Chen J; Wei X; Li Z; Shu J; Hu Z; Jiang X; Sheng H
Clin Chim Acta; 2021 Oct; 521():34-39. PubMed ID: 34144042
[TBL] [Abstract][Full Text] [Related]
16. Presence of Thyroid-Stimulating Hormone Receptor Antibodies in a Patient with Subacute Thyroiditis followed by Hypothyroidism and Later Graves' Disease with Ophthalmopathy: A Case Report.
Hallengren B; Planck T; Åsman P; Lantz M
Eur Thyroid J; 2015 Sep; 4(3):197-200. PubMed ID: 26558237
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease.
Stan MN; Algeciras-Schimnich A; Murthy V; Thapa P; Araki N
Thyroid; 2022 Feb; 32(2):170-176. PubMed ID: 34714163
[No Abstract] [Full Text] [Related]
18. Manifestations of thyroid disease post COVID-19 illness: Report of Hashimoto thyroiditis, Graves' disease, and subacute thyroiditis.
Feghali K; Atallah J; Norman C
J Clin Transl Endocrinol Case Rep; 2021 Dec; 22():100094. PubMed ID: 34462717
[TBL] [Abstract][Full Text] [Related]
19. Hyperthyroidism in an infant of a mother with autoimmune hypothyroidism with positive TSH receptor antibodies.
Joshi K; Zacharin M
J Pediatr Endocrinol Metab; 2018 Apr; 31(5):577-580. PubMed ID: 29494342
[TBL] [Abstract][Full Text] [Related]
20. High Diagnostic Accuracy of Thyroid-Stimulating Hormone (TSH) Receptor Antibodies in Distinguishing Graves' Disease and Subacute Thyrotoxicosis in the Indian Population.
Naga Nitin LT; Lakkundi S; S L SR; Shanthaiah DM; Datta SG; Annavarapu U; Sarathi V
Cureus; 2024 Feb; 16(2):e54303. PubMed ID: 38496158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
